Association of PHB 1630 C > T and MTHFR 677 C > T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study


Por: Jakubowska, A, Rozkrut, D, Antoniou, A, Hamann, U, Scott, RJ, McGuffog, L, Healy, S, Sinilnikova, OM, Rennert, G, Lejbkowicz, F, Flugelman, A, Andrulis, IL, Glendon, G, Ozcelik, H, Thomassen, M, Paligo, M, Aretini, P, Kantala, J, Aroer, B, Von Wachenfeldt, A, Liljegren, A, Loman, N, Herbst, K, Kristoffersson, U, Rosenquist, R, Karlsson, P, Stenmark-Askmalm, M, Melin, B, Nathanson, KL, Domchek, SM, Byrski, T, Huzarski, T, Gronwald, J, Menkiszak, J, Cybulski, C, Serrano, P, Osorio, A, Cajal, TR, Tsitlaidou, M, Benitez, J, Gilbert, M, Rookus, M, Aalfs, CM, Kluijt, I, Boessenkool-Pape, JL, Meijers-Heijboer, HEJ, Oosterwijk, JC, van Asperen, CJ, Blok, MJ, Nelen, MR, van den Ouweland, AMW, Seynaeve, C, van der Luijt, RB, Devilee, P, Easton, DF, Peock, S, Frost, D, Platte, R, Ellis, SD, Fineberg, E, Evans, DG, Lalloo, F, Eeles, R, Jacobs, C, Adlard, J, Davidson, R, Eccles, D, Cole, T, Cook, J, Godwin, A, Bove, B, Stoppa-Lyonnet, D, Caux-Moncoutier, V, Belotti, M, Tirapo, C, Mazoyer, S, Barjhoux, L, Boutry-Kryza, N, Pujol, P, Coupier, I, Peyrat, JP, Vennin, P, Muller, D, Fricker, JP, Venat-Bouvet, L, Johannsson, O, Isaacs, C, Schmutzler, R, Wappenschmidt, B, Meindl, A, Arnold, N, Varon-Mateeva, R, Niederacher, D, Sutter, C, Deissler, H, Preisler-Adams, S, Simard, J, Soucy, P, Durocher, F, Chenevix-Trench, G, Beesley, J, Chen, X, Rebbeck, T, Couch, F, Wang, X, Lindor, N, Fredericksen, Z, Pankratz, VS, Peterlongo, P, Bonanni, B, Fortuzzi, S, Peissel, B, Szabo, C, Mai, PL, Loud, JT, Lubinski, J

Publicada: 5 jun 2012
Resumen:
BACKGROUND: The variable penetrance of breast cancer in BRCA1/2 mutation carriers suggests that other genetic or environmental factors modify breast cancer risk. Two genes of special interest are prohibitin (PHB) and methylene-tetrahydrofolate reductase (MTHFR), both of which are important either directly or indirectly in maintaining genomic integrity. METHODS: To evaluate the potential role of genetic variants within PHB and MTHFR in breast and ovarian cancer risk, 4102 BRCA1 and 2093 BRCA2 mutation carriers, and 6211 BRCA1 and 2902 BRCA2 carriers from the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA) were genotyped for the PHB 1630 C>T (rs6917) polymorphism and the MTHFR 677 C>T (rs1801133) polymorphism, respectively. RESULTS: There was no evidence of association between the PHB 1630 C>T and MTHFR 677 C>T polymorphisms with either disease for BRCA1 or BRCA2 mutation carriers when breast and ovarian cancer associations were evaluated separately. Analysis that evaluated associations for breast and ovarian cancer simultaneously showed some evidence that BRCA1 mutation carriers who had the rare homozygote genotype (TT) of the PHB 1630 C>T polymorphism were at increased risk of both breast and ovarian cancer (HR 1.50, 95% CI 1.10-2.04 and HR 2.16, 95% CI 1.24-3.76, respectively). However, there was no evidence of association under a multiplicative model for the effect of each minor allele. CONCLUSION: The PHB 1630TT genotype may modify breast and ovarian cancer risks in BRCA1 mutation carriers. This association need to be evaluated in larger series of BRCA1 mutation carriers. British Journal of Cancer (2012) 106, 2016-2024. doi:10.1038/bjc.2012.160 www.bjcancer.com Published online 15 May 2012 (C) 2012 Cancer Research UK

Filiaciones:
Jakubowska, A:
 Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland

Rozkrut, D:
 Univ Szczecin, Sch Econ & Management, Dept Stat & Econometr, Szczecin, Poland

Antoniou, A:
 Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge, England

Hamann, U:
 Deutsch Krebsforschungszentrum DKFZ, Dept Funct Genome Anal, Heidelberg, Germany

Scott, RJ:
 Univ Newcastle, Dept Med Genet, Fac Hlth, Callaghan, NSW 2308, Australia

 Hunter Med Res Inst, Newcastle, NSW, Australia

McGuffog, L:
 Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge, England

Healy, S:
 Queensland Inst Med Res, Genet & Populat Hlth Div, Brisbane, Qld 4006, Australia

Sinilnikova, OM:
 Ctr Hosp Univ Lyon, Unite Mixte Genet Constitut Canc Frequents, Hosp Civil Lyon, Ctr Leon Berard Lyon, Lyon, France

 Univ Lyon 1, INSERM, CNRS, U1052,UMR5286,Ctr Rech Cancerol Lyon, F-69365 Lyon, France

Rennert, G:
 Technion Israel Inst Technol, Dept Community Med & Epidemiol, Haifa, Israel

 Technion Israel Inst Technol, Clalit Natl Canc Control Ctr, Carmel Med Ctr, Haifa, Israel

 Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel

Lejbkowicz, F:
 Technion Israel Inst Technol, Dept Community Med & Epidemiol, Haifa, Israel

 Technion Israel Inst Technol, Clalit Natl Canc Control Ctr, Carmel Med Ctr, Haifa, Israel

 Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel

Flugelman, A:
 Technion Israel Inst Technol, Dept Community Med & Epidemiol, Haifa, Israel

 Technion Israel Inst Technol, Clalit Natl Canc Control Ctr, Carmel Med Ctr, Haifa, Israel

 Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel

Andrulis, IL:
 Canc Care Ontario, Dept Mol Genet, Ontario Canc Genet Network, Toronto, ON, Canada

 Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada

Glendon, G:
 Canc Care Ontario, Dept Mol Genet, Ontario Canc Genet Network, Toronto, ON, Canada

 Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada

Ozcelik, H:
 Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada

Thomassen, M:
 Odense Univ Hosp, Dept Clin Genet, DK-5000 Odense, Denmark

Paligo, M:
 Univ Hosp Pisa, Sect Genet Oncol, Pisa, Italy

Aretini, P:
 Univ Hosp Pisa, Sect Genet Oncol, Pisa, Italy

Kantala, J:
 Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden

Aroer, B:
 Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden

Von Wachenfeldt, A:
 Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden

Liljegren, A:
 Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden

Loman, N:
 Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden

Herbst, K:
 Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden

Kristoffersson, U:
 Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden

Rosenquist, R:
 Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden

Karlsson, P:
 Sahlgrens Univ Hosp, Dept Oncol, Gothenburg, Sweden

Stenmark-Askmalm, M:
 Linkoping Univ Hosp, Dept Oncol, S-58185 Linkoping, Sweden

Melin, B:
 Umea Univ, Dept Radiat Sci, Umea, Sweden

Nathanson, KL:
 Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA

 Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA

Domchek, SM:
 Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA

 Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA

Byrski, T:
 Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland

Huzarski, T:
 Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland

Gronwald, J:
 Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland

Menkiszak, J:
 Pomeranian Med Univ, Chair & Dept Surg Gynecol, Szczecin, Poland

Cybulski, C:
 Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland

Serrano, P:
 Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland

Osorio, A:
 Spanish Natl Canc Res Ctr, Human Genet Grp, Madrid, Spain

 Spanish Natl Canc Res Ctr, Genotyping Unit, Human Canc Genet Programme, Madrid, Spain

Cajal, TR:
 Hosp Santa Creu & Sant Pau, Oncol Serv, E-08025 Barcelona, Spain

Tsitlaidou, M:
 Natl Ctr Sci Res Demokritos, Mol Diagnost Lab, IRRP, Athens 15310, Greece

Benitez, J:
 Spanish Natl Canc Res Ctr, Human Genet Grp, Madrid, Spain

 Spanish Natl Canc Res Ctr, Genotyping Unit, Human Canc Genet Programme, Madrid, Spain

Gilbert, M:
 Deutsch Krebsforschungszentrum DKFZ, Dept Funct Genome Anal, Heidelberg, Germany

Rookus, M:
 Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands

Aalfs, CM:
 Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands

Kluijt, I:
 Netherlands Canc Inst, Dept Family Canc Clin, Amsterdam, Netherlands

Boessenkool-Pape, JL:
 Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands

Meijers-Heijboer, HEJ:
 Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands

Oosterwijk, JC:
 Univ Groningen, Univ Med Ctr, Dept Genet, Groningen, Netherlands

van Asperen, CJ:
 Leiden Univ Med Ctr, Dept Clin Genet, Leiden, Netherlands

Blok, MJ:
 Univ Hosp Maastricht, Dept Clin Genet, Maastricht, Netherlands

Nelen, MR:
 Radboud Univ Nijmegen Med Ctr, Dept Human Genet 849, NL-6500 HB Nijmegen, Netherlands

van den Ouweland, AMW:
 Erasmus MC, Dept Clin Genet, Family Canc Clin, Rotterdam, Netherlands

Seynaeve, C:
 Erasmus MC, Dept Med Oncol, Family Canc Clin, Rotterdam, Netherlands

van der Luijt, RB:
 Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands

Devilee, P:
 Leiden Univ Med Ctr, Dept Human Genet, Leiden, Netherlands

 Leiden Univ Med Ctr, Dept Pathol, Leiden, Netherlands

Easton, DF:
 Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England

Peock, S:
 Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England

Frost, D:
 Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England

Platte, R:
 Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England

Ellis, SD:
 Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England

Fineberg, E:
 Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England

Evans, DG:
 NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Cent Manchester Univ Hosp, Manchester, Lancs, England

Lalloo, F:
 NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Cent Manchester Univ Hosp, Manchester, Lancs, England

Eeles, R:
 Royal Marsden NHS Fdn Trust, London, England

Jacobs, C:
 Guys & St Thomas NHS Fdn Trust, London, England

Adlard, J:
 Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England

Davidson, R:
 Yorkhill Hosp, Ferguson Smith Ctr Clin Genet, Glasgow, Lanark, Scotland

Eccles, D:
 Univ Southampton, Fac Med, Southampton Univ Hosp NHS Trust, Southampton SO9 5NH, Hants, England

Cole, T:
 Birmingham Womens Hosp Healthcare NHS Trust, W Midlands Reg Genet Serv, Birmingham, W Midlands, England

Cook, J:
 Sheffield Childrens Hosp, Sheffield Clin Genet Serv, Sheffield, S Yorkshire, England

Godwin, A:
 Univ Kansas Med Ctr, Dept Pathol & Lab Med, Kansas City, KS USA

Bove, B:
 Fox Chase Canc Ctr, Clin Mol Genet Lab, Philadelphia, PA 19111 USA

Stoppa-Lyonnet, D:
 Inst Curie, Serv Genet Oncol, Dept Biol Tumeurs, Paris, France

 Inst Curie, Unite INSERM U830, Paris, France

 Univ Paris 05, Fac Med, Paris, France

Caux-Moncoutier, V:
 Inst Curie, Serv Genet Oncol, Dept Biol Tumeurs, Paris, France

Belotti, M:
 Inst Curie, Serv Genet Oncol, Dept Biol Tumeurs, Paris, France

Tirapo, C:
 Inst Curie, Serv Genet Oncol, Dept Biol Tumeurs, Paris, France

Mazoyer, S:
 Univ Lyon 1, INSERM, CNRS, U1052,UMR5286,Ctr Rech Cancerol Lyon, F-69365 Lyon, France

Barjhoux, L:
 Univ Lyon 1, INSERM, CNRS, U1052,UMR5286,Ctr Rech Cancerol Lyon, F-69365 Lyon, France

Boutry-Kryza, N:
 Ctr Hosp Univ Lyon, Unite Mixte Genet Constitut Canc Frequents, Hosp Civil Lyon, Ctr Leon Berard Lyon, Lyon, France

Pujol, P:
 CHU Arnaud de Villeneuve, Unite Oncogenet, Montpellier, France

 CRCM dAurelle, INSERM 896, Montpellier, France

Coupier, I:
 CHU Arnaud de Villeneuve, Unite Oncogenet, Montpellier, France

 CRLCC Val dAurelle, Unite Oncogenet, Montpellier, France

Peyrat, JP:
 Ctr Oscar Lambret, Lab Oncol Mol Humaine, F-59020 Lille, France

Vennin, P:
 Ctr Oscar Lambret, Consultat Oncogenet, F-59020 Lille, France

Muller, D:
 CLCC Paul Strauss, Unite Oncogenet, Strasbourg, France

Fricker, JP:
 CLCC Paul Strauss, Unite Oncogenet, Strasbourg, France

Venat-Bouvet, L:
 Ctr Hosp Univ Dupuytren, Dept Med Oncol, Limoges, France

Johannsson, O:
 Landspitali Univ Hosp, Dept Oncol, Reykjavik, Iceland

 Univ Iceland, Fac Med, Reykjavik, Iceland

Isaacs, C:
 Georgetown Univ, Dept Med & Oncol, Washington, DC USA

Schmutzler, R:
 Univ Hosp Cologne, Ctr Familial Breast & Ovarian Canc, Dept Obstet & Gynaecol, Cologne, Germany

 Univ Hosp Cologne, Ctr Integrated Oncol, Cologne, Germany

Wappenschmidt, B:
 Univ Hosp Cologne, Ctr Familial Breast & Ovarian Canc, Dept Obstet & Gynaecol, Cologne, Germany

 Univ Hosp Cologne, Ctr Integrated Oncol, Cologne, Germany

Meindl, A:
 Univ Munich, Dept Obstet & Gynaecol, Munich, Germany

Arnold, N:
 Univ Kiel, Dept Obstet & Gynaecol, Univ Hosp Schleswig Holstein, D-24098 Kiel, Germany

Varon-Mateeva, R:
 Inst Human Genet, Charite Berlin, Germany

Niederacher, D:
 Univ Dusseldorf, Dept Obstet & Gynaecol, Univ Hosp Dusseldorf, D-40225 Dusseldorf, Germany

Sutter, C:
 Univ Heidelberg Hosp, Inst Human Genet, Dept Human Genet, Heidelberg, Germany

Deissler, H:
 Univ Hosp Ulm, Dept Obstet & Gynaecol, Ulm, Germany

Preisler-Adams, S:
 Univ Munster, Inst Human Genet, D-4400 Munster, Germany

Simard, J:
 Univ Laval, Quebec City, PQ, Canada

 Ctr Hosp Univ Quebec, Canc Genom Lab, Quebec City, PQ, Canada

Soucy, P:
 Univ Laval, Quebec City, PQ, Canada

 Ctr Hosp Univ Quebec, Canc Genom Lab, Quebec City, PQ, Canada

Durocher, F:
 Univ Laval, Quebec City, PQ, Canada

 Ctr Hosp Univ Quebec, Canc Genom Lab, Quebec City, PQ, Canada

Chenevix-Trench, G:
 Queensland Inst Med Res, Genet & Populat Hlth Div, Brisbane, Qld 4006, Australia

Beesley, J:
 Queensland Inst Med Res, Genet & Populat Hlth Div, Brisbane, Qld 4006, Australia

Chen, X:
 Queensland Inst Med Res, Genet & Populat Hlth Div, Brisbane, Qld 4006, Australia

Rebbeck, T:
 Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA

 Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

Couch, F:
 Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA

 Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA

Wang, X:
 Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA

Lindor, N:
 Mayo Clin, Dept Med Genet, Rochester, MN USA

Fredericksen, Z:
 Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA

Pankratz, VS:
 Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA

Peterlongo, P:
 Fdn IRCCS Ist Nazl Tumori INT, Unit Mol Bases Genet Risk & Genet Testing, Dept Prevent & Predicted Med, Milan, Italy

 Fdn Ist FIRC Oncol Mol, IFOM, Milan, Italy

Bonanni, B:
 Ist Europeo Oncol, Div Canc Prevent & Genet, Milan, Italy

Fortuzzi, S:
 Fdn Ist FIRC Oncol Mol, IFOM 82, Milan, Italy

 84 Cogentech Canc Genet Test Lab, Milan, Italy

Peissel, B:
 Fdn IRCCS Ist Nazl Tumori INT, Unit Med Genet, Dept Prevent & Prevent Med, Milan, Italy

Szabo, C:
 Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA

Mai, PL:
 Dept Hlth & Human Serv, Clin Genet Branch, Div Canc Epidemiol & Genet, NCI,NIH, Rockville, MD 20852 USA

Loud, JT:
 Dept Hlth & Human Serv, Clin Genet Branch, Div Canc Epidemiol & Genet, NCI,NIH, Rockville, MD 20852 USA

Lubinski, J:
 Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland
ISSN: 00070920





BRITISH JOURNAL OF CANCER
Editorial
NATURE PUBLISHING GROUP, MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 106 Número: 12
Páginas: 2016-2024
WOS Id: 000305011100018
ID de PubMed: 22669161
imagen Hybrid Gold, Green Published

MÉTRICAS